The antipsychotic Seroquel generates almost $4.5 billion in yearly sales for AstraZeneca P.L.C. Today, the company hopes, the U.S. Food and Drug Administration will grant permission for Seroquel XR, an extended-release version of the drug, to generate billions more.
Copyright PHILY - Philly.com
